Search results
Here's Why CorMedix (CRMD) Looks Ripe for Bottom Fishing
Zacks via Yahoo Finance· 12 months agoAfter losing some value lately, a hammer chart pattern has been formed for CorMedix (CRMD),...
CorMedix (CRMD) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCorMedix (CRMD) delivered earnings and revenue surprises of 21.74% and 84%, respectively, for the...
CorMedix (CRMD) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. CorMedix (NASDAQ: CRMD) Q4 2023 Earnings Call Mar 12, 2024, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
CorMedix (NASDAQ:CRMD) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 4 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
CorMedix Third Quarter 2022 Earnings: US$0.17 loss per share (vs US$0.23 loss in 3Q 2021)
Simply Wall St. via Yahoo Finance· 1 year agoCorMedix (NASDAQ:CRMD) Third Quarter 2022 ResultsKey Financial Results Net loss: US$6.85m (loss...
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)
Simply Wall St. via Yahoo Finance· 3 weeks agoCorMedix Inc. (NASDAQ:CRMD) is possibly approaching a major achievement in its business, so we would...
CorMedix Slapped With Second FDA Rejection For DefenCath
Benzinga via Yahoo Finance· 2 years agoCorMedix Inc (NASDAQ: CRMD) received a second Complete Response Letter (CRL) from the FDA for...
Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities in Q3 2023
GuruFocus.com via Yahoo Finance· 5 months agoNet loss for Q3 2023 increased to $9.7 million, or $0.17 per share, compared to $6.9 million, or $0.17 per share in Q3 2022. Operating expenses rose by approximately 50% in Q3 2023, driven by ...
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 2 years agoJust because a business does not make any money, does not mean that the stock will go down. For...
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 1 year agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
